Balyasny Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,518,170	Closed	-$13.8M	–	3456
2025 Q2	$13.8M	Buy	1,518,170 +1,404,441	+1,235%	+$10.3M	0.03%	815
2025 Q1	$904K	Buy	+113,729	New	+$833K	﹤0.01%	2037
2022 Q4	–	Sell	-33,794	Closed	-$1.32M	–	3227
2022 Q3	$1.32M	Sell	33,794 -301,872	-90%	-$11.7M	0.01%	1688
2022 Q2	$10.8M	Buy	335,666 +316,390	+1,641%	+$10.6M	0.05%	625
2022 Q1	$638K	Buy	+19,276	New	+$725K	﹤0.01%	1751
2021 Q4	–	Hold	0	–	–	–	2618
2021 Q3	–	Hold	0	–	–	–	2449
2020 Q4	–	Sell	-142,289	Closed	-$8.7M	–	1702
2020 Q3	$8.7M	Buy	+142,289	New	+$7.21M	0.08%	429
2020 Q2	–	Sell	-19,038	Closed	-$547K	–	1497
2020 Q1	$547K	Sell	19,038 -133,467	-88%	-$7.73M	0.01%	886
2019 Q4	$11M	Buy	+152,505	New	+$18.8M	0.07%	399
2019 Q1	–	Hold	0	–	–	–	1638
2018 Q4	–	Sell	-75,593	Closed	-$8.65M	–	1733
2018 Q3	$10.7M	Buy	75,593 +61,362	+431%	+$9.47M	0.06%	471
2018 Q2	$2.23M	Sell	14,231 -223,900	-94%	-$35.2M	0.01%	895
2018 Q1	$38.4M	Sell	238,131 -23,069	-9%	-$3.92M	0.19%	178
2017 Q4	$43M	Sell	261,200 -98,602	-27%	-$9.56M	0.15%	186
2017 Q3	$22.4M	Buy	359,802 +169,302	+89%	+$13.3M	0.1%	298
2017 Q2	$15.2M	Sell	190,500 -65,443	-26%	-$4.73M	0.07%	402
2017 Q1	$18.2M	Sell	255,943 -121,417	-32%	-$7.11M	0.1%	305
2016 Q4	$19.3M	Buy	377,360 +147,354	+64%	+$6.95M	0.12%	282
2016 Q3	$10.6M	Buy	230,006 +118,097	+106%	+$4.81M	0.06%	376
2016 Q2	$3.37M	Buy	+111,909	New	+$3.73M	0.03%	594
2016 Q1	–	Sell	-26,250	Closed	-$1.53M	–	1537
2015 Q4	$1.53M	Buy	+26,250	New	+$1.3M	0.01%	675

Other funds holding SAGE